Associate
Jordan prosecutes patent applications before the U.S. Patent and Trademark Office (USPTO). His experience includes drafting applications for inventions relating to genetically modified bacteria constructs. He also provides opinions on validity and freedom to operate for clients in the pharmaceutical and biotechnology industries.
While in law school, Jordan worked as a summer associate at Finnegan and he interned with Unified Patents. At Unified, he assisted senior counsel in selecting patents for inter partes review (IPR) challenges before the USPTO.
Prior to law school, Jordan conducted immunology research in the Snapper Lab at Harvard's Boston Children's Hospital. His research helped assess the clinical efficacy of low-dose interleukin-2 (IL2) for patients with ulcerative colitis and develop a humanized mouse model used to assess a wide range of inflammatory bowel disease (IBD) treatments. He also investigated the interplay between genes and bacteria in relation to IBD. Jordan is a listed author on several published articles in prestigious journals, such as Gastroenterology.
Articles
Southeast Litigation Update: February 2024 Southeast Litigation Update: February 2024
April 15, 2024
Articles
Southeast Litigation Update: January 2024 Southeast Litigation Update: January 2024
March 7, 2024
Articles
Potential Implications of Inflation Reduction Act on Pharmaceutical Patent Litigation Potential Implications of Inflation Reduction Act on Pharmaceutical Patent Litigation
May 1, 2023
Bloomberg LawProsecution First Blog
The Eastern District of Arkansas Holds Key Claim Terms Indefinite in Enviro Tech. v. Safe Foods Corp. The Eastern District of Arkansas Holds Key Claim Terms Indefinite in Enviro Tech. v. Safe Foods Corp.
March 3, 2023
IP Health Blog
FDA Guidance on Quality Considerations for Clinical Research Involving Cannabis and Cannabis-Derived Compounds FDA Guidance on Quality Considerations for Clinical Research Involving Cannabis and Cannabis-Derived Compounds
February 24, 2023
Federal Circuit IP Blog
Spotlight on Upcoming Oral Arguments – February 2023 Spotlight on Upcoming Oral Arguments – February 2023
February 3, 2023
Admitted in Florida only; practicing under the supervision of the partners of the Washington, DC office of Finnegan.
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.